Endo in a Bite
Episodes
AHA ACC Measurement of TC, LDL C, HDL C, TG, and Non-HDL C
20 Apr 2026
Contributed by Lukas
This episode reviews standard lipid measurements for cardiovascular risk assessment based on AHA/ACC guidelines. It highlights the use of non-fasting ...
AHA ACC Screening For Dyslipidemia In Children And Adults
13 Apr 2026
Contributed by Lukas
This episode reviews the importance of dyslipidemia screening across both pediatric and adult populations based on AHA ACC guidelines. It highlights t...
Hypoglycemia (ADA Standards of Care; Mentioned in ESAP 2026)
06 Apr 2026
Contributed by Lukas
This episode reviews the clinical significance of hypoglycemia in diabetes care, including its classification into Level 1, Level 2, and Level 3 event...
Vitamin D (Endocrine Society 2024; Mentioned in ESAP 2026)
30 Mar 2026
Contributed by Lukas
This episode reviews the evolution of vitamin D management frameworks, highlighting the shift from intake based recommendations by the National Academ...
Key Clinical Points on Semaglutide (ESAP 2026)
23 Mar 2026
Contributed by Lukas
This episode reviews clinical management of gastrointestinal symptoms associated with semaglutide therapy and strategies to maintain treatment when in...
Cardiovascular Kidney Metabolic Syndrome (AHA 2023; Mentioned in ESAP 2026)
16 Mar 2026
Contributed by Lukas
This episode reviews the cardiovascular kidney metabolic (CKM) syndrome framework introduced by the American Heart Association, which describes the in...
The PREVENT Calculator and Lipid Risk Enhancers (Mentioned in ESAP 2026)
09 Mar 2026
Contributed by Lukas
This episode reviews the American Heart Association PREVENT™ cardiovascular risk calculator and its role in modern primary prevention. The discussio...
Obesity: Part 8 (Individualized Pharmacotherapy - 2025 AACE Update)
02 Mar 2026
Contributed by Lukas
This episode reviews the 2025 ACE consensus framework for individualized obesity pharmacotherapy, moving beyond standardized algorithms toward conditi...
Obesity: Part 7 (Cost Conscious Pharmacotherapy - 2025 AACE Update)
23 Feb 2026
Contributed by Lukas
This episode reviews the 2025 ACE consensus approach to cost conscious obesity pharmacotherapy, emphasizing access driven treatment sequencing, payer ...
Obesity: Part 6 (Complication Centric Pharmacotherapy - 2025 AACE Update)
16 Feb 2026
Contributed by Lukas
This episode reviews the 2025 ACE consensus on complication centric obesity management, with a focus on organ system based medication prioritization. ...
Obesity: Part 5 (Lifestyle Therapy and Long Term Management - 2025 AACE Update)
09 Feb 2026
Contributed by Lukas
This episode reviews the 2025 ACE consensus on biologically informed lifestyle therapy for obesity and adiposity based chronic disease (ABCD), includi...
Obesity: Part 4 (Response and Targets - 2025 AACE Update)
02 Feb 2026
Contributed by Lukas
This episode reviews the 2025 ACE consensus on therapeutic weight loss response, threshold based outcomes, early pharmacologic response assessment, an...
Obesity: Part 3 (Clinical Component of ABCD - 2025 AACE Update)
26 Jan 2026
Contributed by Lukas
This episode reviews the clinical component of the 2025 ACE consensus, shifting from identifying excess adiposity to staging adiposity based chronic d...
Obesity: Part 2 (Anthropometric Component of ABCD - 2025 AACE Update)
19 Jan 2026
Contributed by Lukas
This episode examines the anthropometric component of the 2025 ACE consensus on obesity, emphasizing the role of BMI as a screening tool rather than ...
Obesity: Part 1 ( Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity Based Chronic Disease - 2025 AACE Update)
12 Jan 2026
Contributed by Lukas
This episode introduces the 2025 ACE consensus framework for obesity, reframing the condition as adiposity based chronic disease (ABCD) rather than a ...
Management of Dyslipidemia: Part 10 (Special Populations)
05 Jan 2026
Contributed by Lukas
This episode reviews the management of dyslipidemia in special populations using an individualized, risk based framework. It emphasizes ASCVD risk ass...
Management of Dyslipidemia: Part 9 (Statins & LDL Lowering Therapy)
29 Dec 2025
Contributed by Lukas
This episode reviews guideline directed statin therapy and LDL lowering strategies using ASCVD risk based statin benefit groups. It emphasizes selecti...
Management of Dyslipidemia: Part 8 (High TG in Pregnancy)
22 Dec 2025
Contributed by Lukas
This episode reviews the management of hypertriglyceridemia in pregnancy using a triglyceride level guided framework. It emphasizes risk stratificatio...
Management of Dyslipidemia: Part 7 (High TG Treatment)
15 Dec 2025
Contributed by Lukas
This episode reviews the evaluation and management of adult hypertriglyceridemia using a triglyceride level driven framework. Emphasis is placed on ri...
Management of Dyslipidemia: Part 6 (High TG Classification)
08 Dec 2025
Contributed by Lukas
This episode breaks down hypertriglyceridemia in adults, covering classification by level, etiology, particle type, and clinical risk orientation.
Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 5)
01 Dec 2025
Contributed by Lukas
This episode reviews the evaluation of adults with severe hypertriglyceridemia, according to the 2025 AACE Algorithm.• Severe Hypertriglyceridemia...
Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 4)
24 Nov 2025
Contributed by Lukas
This episode reviews how to evaluate and manage adults with extremely low or extremely high HDL cholesterol according to the 2025 AACE Algorithm.• I...
Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 3)
17 Nov 2025
Contributed by Lukas
This episode reviews how to evaluate and manage adults with very low LDL cholesterol (<40 mg/dL) according to the 2025 AACE Algorithm.• Identifie...
Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 2)
10 Nov 2025
Contributed by Lukas
This episode explores the next step in the 2025 AACE Dyslipidemia Management Algorithm, focusing on adults with LDL cholesterol levels of 190 mg/dL or...
Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 1)
03 Nov 2025
Contributed by Lukas
This episode serves as the introduction to the series on the 2025 AACE Dyslipidemia Management Algorithm, focusing on patient centered risk assessment...
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 10
27 Oct 2025
Contributed by Lukas
In this episode, we review recommendations 73 to 84 from the 2025 American Thyroid Association guidelines on managing radioiodine refractory different...
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 9
20 Oct 2025
Contributed by Lukas
In this episode, we review recommendations 57 to 72 from the 2025 American Thyroid Association guidelines on the management of radioiodine avid and ra...
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 8
13 Oct 2025
Contributed by Lukas
In this episode, we review recommendations 51 to 56 from the 2025 American Thyroid Association guidelines on long term management of differentiated th...
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 7
06 Oct 2025
Contributed by Lukas
In this episode, we review recommendations 45 to 50 from the 2025 American Thyroid Association guidelines on long term management of differentiated th...
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 6
29 Sep 2025
Contributed by Lukas
In this episode, we break down recommendations 41 to 44 from the 2025 American Thyroid Association guidelines on differentiated thyroid cancer managem...
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 5
22 Sep 2025
Contributed by Lukas
In this episode, we review key updates from the 2025 American Thyroid Association guidelines on surveillance and radioactive iodine management for adu...
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 4
15 Sep 2025
Contributed by Lukas
In this episode, we break down recommendations 21 to 30 from the 2025 American Thyroid Association guidelines on differentiated thyroid cancer managem...
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 3
08 Sep 2025
Contributed by Lukas
In this episode, we review key updates from the 2025 American Thyroid Association guidelines on surgical management for adult patients with differenti...
New Primary Aldosteronism – Endocrine Society 2025 Guidelines; Bonus Summary Episode 5
08 Sep 2025
Contributed by Lukas
This bonus summary episode distills the Endocrine Society’s 2025 guideline updates on primary aldosteronism into high yield pearls for clinical prac...
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 2
01 Sep 2025
Contributed by Lukas
In this episode, we review key updates from the 2025 ATA guidelines on surgical referral, imaging, and risk based management for adult patients with d...
New Primary Aldosteronism Guidelines – Endocrine Society 2025; Episode 4
01 Sep 2025
Contributed by Lukas
This episode reviews the Endocrine Society’s 2025 guideline updates on managing primary aldosteronism after initial screening.• When suppression t...
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 1
25 Aug 2025
Contributed by Lukas
In this episode, we review the ATA 2025 thyroid cancer guideline updates on tumors of uncertain malignant potential and when germline genetic testing ...
New Primary Aldosteronism Guidelines – Endocrine Society 2025; Episode 3 of 4
25 Aug 2025
Contributed by Lukas
This episode reviews medications and hormonal therapies that can falsely raise the Aldosterone-to-Renin Ratio (ARR), creating false-positive results i...
New Primary Aldosteronism Guidelines – Endocrine Society 2025; Episode 2 of 4
18 Aug 2025
Contributed by Lukas
This episode reviews my key notes on medications and factors that can falsely lower the Aldosterone-to-Renin Ratio (ARR), leading to missed cases of p...
New Primary Aldosteronism Guidelines – Endocrine Society 2025; Episode 1 of 4
11 Aug 2025
Contributed by Lukas
• Four-part series highlighting my personal notes and key clinical insights from the newly released 2025 Endocrine Society guidelines on Primary Ald...
Lipoprotein(a): What Every Endocrinologist Should Know
04 Aug 2025
Contributed by Lukas
This high-yield episode breaks down exactly why Lp(a) is gaining attention as a critical cardiovascular risk factor. It's genetically determined, ...
MASLD & MASH: Concise Clinical and Board Pearls
28 Jul 2025
Contributed by Lukas
Ready to master MASLD and MASH for your boards and daily practice? This episode cuts straight to the chase, delivering crucial, latest pearls on this ...
Vaccines in Patients with Diabetes
09 Jul 2025
Contributed by Lukas
Are you staying sharp for boards or brushing up on practical diabetes care? This quick episode covers the most up to date vaccine guidelines for patie...